IMI ANNOUNCES CLINICAL TRIAL WITH COLORECTALERT

IMI International Medical Innovations announced a collaborative research agreement with members of the U.S. National Cancer Institute's (NCI's) Early Detection Research Network's (EDRN's) Great Lakes-New England Clinical Epidemiology Center Consortium to include IMI's ColorectAlert test in a major colorectal cancer clinical trial. The EDRN, funded by the NCI, focuses on the development, testing and evaluation of promising biomarkers or technologies for the early detection of cancer.

Yahoo News (http://biz.yahoo.com/prnews/050705/to138.html?.v=8)